Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The impact of receptor of advanced glycation end-products polymorphisms on prostate cancer progression and clinicopathological characteristics.

Journal of cellular and molecular medicine - 1 Nov 2021

Chou Ying-Erh, Hsieh Ming-Ju, Wang Shian-Shiang, Lin Chia-Yen, Chen Yen-Yu, Ho Yung-Chuan, Yang Shun-Fa

Abstract excerpt

The receptor for advanced glycation end products (RAGE) overexpression was suggested to be associated with prostate cancer development and poor prognosis. In this study, we focused on the correlations between the clinicopathological characteristics and susceptibility of prostate cancer and RAGE single-nucleotide polymorphisms (SNPs). In 579 prostate cancer patients, the RAGE SNPs rs1800625, rs1800624, rs2070600...

Read the complete abstract on PubMed

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Alleles
Share to Genetic Association Studies
Share to Neoplasm Grading
Share to Neoplasm Staging
Share to Odds Ratio
Share to Prostatic Neoplasms
Share to Receptor for Advanced Glycation End Products

Source

Open in PubMed Open full text

Identifiers

PMID: 34708514
DOI: 10.1111/jcmm.17025
PMCID: PMC8581310

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

The impact of receptor of advanced glycation end-products polymorphisms on prostate cancer progression and clinicopathological characteristics.PMID 34708514Read ↗

Prognostic Value of Prostaglandin-endoperoxide Synthase 2 Polymorphisms in Prostate Cancer Recurrence after Radical Prostatectomy.Semantic proximity Read ↗

Impact of Matrix Metalloproteinase-11 Gene Polymorphisms on Biochemical Recurrence and Clinicopathological Characteristics of Prostate Cancer.Semantic proximity Read ↗

Subtypes of m6A RNA Modification Defines Tumor Microenvironment, Immunotherapy and Pharmacogenomic Landscape in Prostate CancerSemantic proximity Read ↗

Differentially Expressed Genes Associated With Prognosis in Locally Advanced Lymph Node-Negative Prostate CancerSemantic proximity Read ↗

TOP2A and PPARGC1A differentiate chromatin regulator-related subtypes for prostate cancer patients undergoing radical prostatectomySemantic proximity Read ↗

5 Gleason score-associated gene signatures serve as novel biomarkers for identifying early recurring events and contributing to early diagnosis for Prostate AdenocarcinomaSemantic proximity Read ↗

A novel immune-related gene-based prognostic signature to predict biochemical recurrence in patients with prostate cancer after radical prostatectomySemantic proximity Read ↗

A N7-Methylguanine-Related Gene Signature Applicable for the Prognosis and Microenvironment of Prostate CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.